PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

NCT04199741 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer
Small Cell Lung Carcinoma

Interventions

DRUG: 89Zr-DFO-SC16.56
DRUG: SC16.56, Phase I, Cohort 2
DRUG: SC16.56, Phase I, Cohort 3
DRUG: SC16.56, Phase II

Sponsor

Memorial Sloan Kettering Cancer Center